insights_auto
Outlook: 29.3% bullish·22.7% bearish
Go to analysischevron_right
MRNA:NASDAQ
Moderna Inc
US$190,01
arrow_upward
+0,57%(+1,07) 1D
US$189,64
arrow_downward
-0,19% (-0,37)bedtimeAfter hours
Closed: 2 ຕ.ລ., 16 ໂມງ 0 ນາທີ 01 ວິນາທີ GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for MRNA...
Open
US$190,26
High
US$193,72
Low
US$183,28
Mkt. cap
75,86 ຕື້
Avg. vol.
23,19 ລ້ານ
Volume
10,29 ລ້ານ
52-wk high
US$208,90
52-wk low
US$22,29
EPS
US$-7,98
Beta
1,09
Shares outstanding
399,24 ລ້ານ
No. of employees
5 ພັນ
Open
US$190,26
High
US$193,72
Low
US$183,28
Mkt. cap
75,86 ຕື້
Avg. vol.
23,19 ລ້ານ
Volume
10,29 ລ້ານ
52-wk high
US$208,90
52-wk low
US$22,29
EPS
US$-7,98
Beta
1,09
Shares outstanding
399,24 ລ້ານ
No. of employees
5 ພັນ
News stories
From web sources and news partners
GuruFocus
·
2 ຊົ່ວໂມງກ່ອນ
Moderna (MRNA) Shares Surge on Cancer Vaccine Optimism Despite C
Seeking Alpha
·
3 ຊົ່ວໂມງກ່ອນ
SA Asks: Is Moderna's stock now a sell after the recent run-up? (MRNA:NASDAQ)
AD HOC NEWS
·
5 ຊົ່ວໂມງກ່ອນ
Moderna stock gained 0.57 percent as Nasdaq-100 entry nears
Simply Wall Street
·
1 ມື້ກ່ອນ
Moderna (MRNA) Stock Looks Too Expensive For Its Sales Story
Profile
Moderna, Inc. is an American pharmaceutical and biotechnology company based in Cambridge, Massachusetts, that focuses on RNA therapeutics, primarily mRNA vaccines. These vaccines use a copy of a molecule called messenger RNA to carry instructions for proteins to produce an immune response. The company's name is derived from the terms "modified", "RNA", and "modern".
The company's commercial products are the Moderna COVID-19 vaccine sold under the brand names Spikevax and Mnexspike, a respiratory syncytial virus vaccine sold under the brand name Mresvia, and an influenza vaccine sold under the brand name Mflusiva. The company has 44 treatment and vaccine candidates, of which 37 have entered clinical trials. Candidates include possible vaccines for influenza, HIV, Epstein–Barr virus, the Nipah virus, chikungunya, human metapneumovirus, varicella zoster virus, as well as a cytomegalovirus vaccine, a Zika virus vaccine funded by the Biomedical Advanced Research and Development Authority, and three cancer vaccines.
In May 2026, Time ranked Moderna first in their list of the World's Most Impactful Companies. Wikipedia
About Moderna Inc
CEOStéphane Bancel
Employees4,7 ພັນ
Foundedກ.ຍ. 2010
Headquarters-
SectorBiotechnology
Websitemodernatx.com